Northern Trust’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.1M Sell
1,913,729
-41,529
-2% -$372K ﹤0.01% 1735
2025
Q1
$14.7M Sell
1,955,258
-49,653
-2% -$372K ﹤0.01% 1815
2024
Q4
$15.1M Buy
2,004,911
+143,986
+8% +$1.08M ﹤0.01% 1879
2024
Q3
$14.1M Buy
1,860,925
+106,162
+6% +$807K ﹤0.01% 1852
2024
Q2
$10.8M Sell
1,754,763
-50,412
-3% -$312K ﹤0.01% 1947
2024
Q1
$9.17M Sell
1,805,175
-41,591
-2% -$211K ﹤0.01% 2089
2023
Q4
$11.1M Sell
1,846,766
-5,897
-0.3% -$35.3K ﹤0.01% 1992
2023
Q3
$13.1M Buy
1,852,663
+15,142
+0.8% +$107K ﹤0.01% 1820
2023
Q2
$12.9M Buy
1,837,521
+74,422
+4% +$524K ﹤0.01% 1873
2023
Q1
$14.7M Buy
1,763,099
+15,639
+0.9% +$130K ﹤0.01% 1759
2022
Q4
$20.1M Sell
1,747,460
-49,331
-3% -$566K ﹤0.01% 1518
2022
Q3
$22.6M Sell
1,796,791
-20,093
-1% -$253K 0.01% 1380
2022
Q2
$19.2M Buy
1,816,884
+16,986
+0.9% +$180K ﹤0.01% 1549
2022
Q1
$29.3M Sell
1,799,898
-61,110
-3% -$994K 0.01% 1403
2021
Q4
$25.8M Sell
1,861,008
-576,576
-24% -$7.99M ﹤0.01% 1594
2021
Q3
$35M Sell
2,437,584
-22,728
-0.9% -$327K 0.01% 1367
2021
Q2
$38.9M Buy
2,460,312
+508,184
+26% +$8.03M 0.01% 1359
2021
Q1
$19.9M Sell
1,952,128
-110,979
-5% -$1.13M ﹤0.01% 1828
2020
Q4
$15.4M Sell
2,063,107
-27,319
-1% -$204K ﹤0.01% 1976
2020
Q3
$7.18M Buy
2,090,426
+162,200
+8% +$557K ﹤0.01% 2310
2020
Q2
$9.19M Buy
1,928,226
+59,096
+3% +$282K ﹤0.01% 2149
2020
Q1
$3.74M Buy
1,869,130
+38,698
+2% +$77.4K ﹤0.01% 2472
2019
Q4
$6.32M Buy
1,830,432
+462,630
+34% +$1.6M ﹤0.01% 2455
2019
Q3
$3.92M Buy
1,367,802
+4,753
+0.3% +$13.6K ﹤0.01% 2684
2019
Q2
$5.17M Buy
1,363,049
+2,115
+0.2% +$8.01K ﹤0.01% 2542
2019
Q1
$11.1M Buy
1,360,934
+10,318
+0.8% +$84K ﹤0.01% 2080
2018
Q4
$10.9M Sell
1,350,616
-3,217
-0.2% -$26K ﹤0.01% 2015
2018
Q3
$10.3M Buy
1,353,833
+139,272
+11% +$1.06M ﹤0.01% 2238
2018
Q2
$6.96M Buy
1,214,561
+25,685
+2% +$147K ﹤0.01% 2494
2018
Q1
$5.67M Buy
1,188,876
+13,044
+1% +$62.2K ﹤0.01% 2512
2017
Q4
$5.77M Buy
1,175,832
+164,957
+16% +$810K ﹤0.01% 2521
2017
Q3
$5.3M Buy
1,010,875
+4,035
+0.4% +$21.1K ﹤0.01% 2593
2017
Q2
$5.6M Buy
1,006,840
+98,077
+11% +$545K ﹤0.01% 2554
2017
Q1
$7.63M Buy
908,763
+36,243
+4% +$304K ﹤0.01% 2301
2016
Q4
$5.52M Buy
872,520
+16,529
+2% +$105K ﹤0.01% 2488
2016
Q3
$3.78M Sell
855,991
-7,934
-0.9% -$35K ﹤0.01% 2706
2016
Q2
$2.45M Buy
863,925
+31,262
+4% +$88.8K ﹤0.01% 2916
2016
Q1
$2.41M Sell
832,663
-71,123
-8% -$206K ﹤0.01% 2868
2015
Q4
$9.33M Buy
903,786
+4,654
+0.5% +$48K ﹤0.01% 2064
2015
Q3
$10.3M Buy
899,132
+81,651
+10% +$931K ﹤0.01% 1978
2015
Q2
$12.2M Sell
817,481
-11,457
-1% -$171K ﹤0.01% 1934
2015
Q1
$7.49M Sell
828,938
-10,128
-1% -$91.5K ﹤0.01% 2246
2014
Q4
$10.2M Sell
839,066
-2,161
-0.3% -$26.3K ﹤0.01% 2031
2014
Q3
$8.23M Buy
841,227
+603,137
+253% +$5.9M ﹤0.01% 2174
2014
Q2
$3.04M Buy
238,090
+123,186
+107% +$1.57M ﹤0.01% 2840
2014
Q1
$1.22M Sell
114,904
-87
-0.1% -$920 ﹤0.01% 3344
2013
Q4
$874K Buy
114,991
+11,480
+11% +$87.3K ﹤0.01% 3416
2013
Q3
$753K Sell
103,511
-391,536
-79% -$2.85M ﹤0.01% 3388
2013
Q2
$767K Buy
+495,047
New +$767K ﹤0.01% 3344